Epilepsy in the Sanaga-Mbam valley, an onchocerciasis-endemic region in Cameroon: electroclinical and neuropsychological findings.


Journal

Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036

Informations de publication

Date de publication:
09 2021
Historique:
revised: 17 04 2021
received: 14 12 2020
accepted: 20 04 2021
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 19 3 2022
Statut: ppublish

Résumé

Epilepsy is highly prevalent in onchocerciasis-endemic African regions. Various types of epilepsy have been described in such regions based essentially on clinical characteristics. We conducted a clinical, neurophysiological and neuropsychological study of epilepsy in the onchocerciasis-endemic region of Ntui, Sanaga-Mbam area, Cameroon. One hundred and eighty-seven persons with presumed epilepsy were recruited in an epilepsy clinic in Ntui. Epilepsy was clinically confirmed in 144 (79%) subjects, 69 (46.0%) of them met the onchocerciasis-associated epilepsy (OAE) criteria, and 51 of 106 tested (48.1%) presented Ov16 antibodies. Electroencephalograms (EEG) were recorded in 91 participants, of which 36 (33%) were considered abnormal and 27 of 36 (75%) revealed bifrontotemporal spike and slow waves. Concerning the neuropsychological evaluation, 29% showed severe global cognitive impairment, 28% severe episodic memory impairment, and 66% severe frontal cognitive impairment. Half of the persons with epilepsy (PWE) suffered from a mental disorder. In PWE in the Sanaga-Mbam area in Cameroon, we observed EEG patterns similar to those described among persons with OAE, including nodding syndrome in other onchocerciasis-endemic areas. Most PWE presented with severe cognitive impairment. We hypothesize that onchocerciasis may induce neurocognitive disorders and epilepsy via a mechanism that involves mainly the frontal and temporal regions of the brain.

Identifiants

pubmed: 35138694
doi: 10.1002/epi4.12510
pmc: PMC8408605
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-527

Informations de copyright

© 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Epileptic Disord. 2019 Oct 1;21(5):425-435
pubmed: 31649005
PLoS Negl Trop Dis. 2009 Jun 16;3(6):e461
pubmed: 19529767
PLoS Negl Trop Dis. 2019 Jul 18;13(7):e0007407
pubmed: 31318857
Lancet. 1983 Feb 12;1(8320):358
pubmed: 6130361
Lancet Infect Dis. 2020 Nov;20(11):1315-1323
pubmed: 32598869
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Epilepsia. 2009 Sep;50(9):2167-8
pubmed: 19706061
Seizure. 2015 Sep;31:64-71
pubmed: 26362379
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319
Appl Neuropsychol. 2000;7(4):252-8
pubmed: 11296689
Acta Neuropathol. 2018 Nov;136(5):691-697
pubmed: 30219940
Epilepsy Behav. 2020 Nov;112:107437
pubmed: 32920377
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Epilepsy Res. 2008 Dec;82(2-3):200-10
pubmed: 18976884
PLoS One. 2013 Jun 18;8(6):e66419
pubmed: 23823012
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Epilepsia. 2014 Jan;55(1):86-93
pubmed: 24359274
BMJ Open. 2013 May 03;3(5):
pubmed: 23645924
Lancet Neurol. 2013 Mar;12(3):253-63
pubmed: 23375964
Epileptic Disord. 2020 Jun 1;22(3):301-308
pubmed: 32540799
PLoS Negl Trop Dis. 2013;7(3):e2147
pubmed: 23556028
Lancet Neurol. 2005 Jan;4(1):21-31
pubmed: 15620854
PLoS Negl Trop Dis. 2021 Jan 7;15(1):e0008965
pubmed: 33411705
Epilepsy Behav. 2009 Oct;16(2):254-9
pubmed: 19751991
Infect Dis Poverty. 2018 Mar 22;7(1):23
pubmed: 29580280
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
Infect Dis Poverty. 2018 Dec 3;7(1):114
pubmed: 30501640
Open Forum Infect Dis. 2020 Jun 02;7(6):ofaa206
pubmed: 32587878
Lancet Neurol. 2014 Oct;13(10):1029-44
pubmed: 25231525
J Neuropathol Exp Neurol. 2019 Nov 1;78(11):1049-1058
pubmed: 31553445
PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300
pubmed: 31314757
Acta Neurol Scand. 1990 Jun;81(6):504-6
pubmed: 2220307
Lancet Neurol. 2013 Feb;12(2):166-74
pubmed: 23305742
Seizure. 2018 Dec;63:93-101
pubmed: 30468964
Parasit Vectors. 2019 Mar 19;12(1):114
pubmed: 30890155
Infect Dis Poverty. 2020 Mar 2;9(1):12
pubmed: 32114979

Auteurs

Alexandre Morin (A)

Department of Neurology, Rouen University Hospital, Rouen, France.

Maxime Guillaume (M)

Department of Neurology, Rouen University Hospital, Rouen, France.

Leonard Ngarka (L)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Department of Neurology, Yaoundé Central Hospital/Faculty of Medicine and Biomedical Sciences, The University of Yaoundé 1, Yaoundé, Cameroon.

Godwin Y Tatah (GY)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Department of Neurology, CH Saint-Nazaire, Saint-Nazaire, France.

Joseph Nelson Siewe Fodjo (JN)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Global Health Institute, University of Antwerp, Antwerp, Belgium.

Guillaume Wyart (G)

Oniris Nantes, Nantes, France.

Ghislain Nokam (G)

Neurology clinic, Touques, France.

Thierry Tchoumi (T)

Neurology unit, Hospital Center De Saintonge, Saintes, France.

Mary Bello Nkinin (MB)

Department of Neurology, Yaoundé Central Hospital/Faculty of Medicine and Biomedical Sciences, The University of Yaoundé 1, Yaoundé, Cameroon.

Wepnyu Y Njamnshi (WY)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Department of Neurology, Yaoundé Central Hospital/Faculty of Medicine and Biomedical Sciences, The University of Yaoundé 1, Yaoundé, Cameroon.

Eric-Samuel Chokote (ES)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.

Michel Boussinesq (M)

UMI 233, Institut de Recherche pour le Développement (IRD)/Research and Development Institute, Montpellier, France.
Montpellier University, Montpellier, France.
INSERM Unit 1175, Montpellier, France.

Robert Colebunders (R)

Global Health Institute, University of Antwerp, Antwerp, Belgium.

Cédric B Chesnais (CB)

UMI 233, Institut de Recherche pour le Développement (IRD)/Research and Development Institute, Montpellier, France.
Montpellier University, Montpellier, France.
INSERM Unit 1175, Montpellier, France.

Gilles Gargala (G)

Laboratory of Parasitology-Mycology & EA7510, Rouen University Hospital, Rouen, France.

Dominique Parain (D)

Neuropsychiatric Clinic, Rouen, France.

Alfred K Njamnshi (AK)

Brain Research Africa Initiative (BRAIN), Geneva, Switzerland.
Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon.
Department of Neurology, Yaoundé Central Hospital/Faculty of Medicine and Biomedical Sciences, The University of Yaoundé 1, Yaoundé, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH